DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Protect Your Eyes: A Baseball Player’s Story
Thyroid eye disease, also known as Graves’ eye disease, sometimes occurs in those with Graves’ hyperthyroidism. In patients with thyroid disease, the thyroid gland enlarges and produces excess hormones, which can cause an abnormal reaction in the muscles and fatty tissue around the eyes. Eye muscles and connective tissue in the eye sockets are particularly vulnerable to excess hormones, perhaps because the tissue contains proteins that the immune system recognizes as belonging to the thyroid gland.
Symptoms may include dry or watery eyes, a feeling of pressure in the eye socket, bulging eyes, sensitivity to light, double vision, or other vision issues. Swelling may cause the eyes to look puffy, and in some cases muscles may tighten and pull back from the eyes, causing a perpetually startled look.
Roughly one million Americans are diagnosed with thyroid eye disease each year, and women are more than five times more likely to get the disease than men.

Related Content
-
Evidence & EducationEfficacy and Safety of Mycophenolate Mofetil in Patients With Active Moderate-to-Severe Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
-
News & MeetingsHorizon Therapeutics plc Reports Strong Third-Quarter 2019 ResultsHorizon Therapeutics plc today announced...
-
Evidence & EducationMycophenolate Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-Severe Graves’ Or...Background: European guidelines recomme...
-
People & PlacesJulian Perry, MDJulian Perry, MD received his medical de...
-
News & MeetingsBreakthrough Treatment for Thyroid Eye DiseaseFor those with severe inflammation from ...
-
Community CenterMy Struggle and Success to Stay Positive While Struggling with TEDI admit that Graves' disease and thyroid...
-
Evidence & EducationEvaluation of Depression and Anxiety in a Diverse Population With Thyroid Eye Disease Using the Nationwide NIH All o...Purpose: To evaluate the prevalence o...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.